P1.01-114 A Phase 2 Study of MLN4924 (Pevonedistat) in Combination with Carboplatin and Paclitaxel in Advanced NSCLC Previously Treated with Immunotherapy
JOURNAL OF THORACIC ONCOLOGY(2019)
关键词
NSCLC,MLN4924(Pevonedistat),Carboplatin/paclitaxel
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要